DRUG · Unmapped registry intervention
High Dose ALKS 5461
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study
NCT02158533
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Low Dose ALKS 5461
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Sponsors & collaborators
Alkermes, Inc.lead sponsor
Mapped research locations
BaltimoreMaryland, United States2Oklahoma CityOklahoma, United States2New YorkNew York, United States1HoustonTexas, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1San AntonioTexas, United States1BirminghamAlabama, United States1OrlandoFlorida, United States1AustinTexas, United States1TucsonArizona, United States1GainesvilleFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02158533 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.